Evidence map›Paper›PMID 39786674›Full record

ArticlePhysical and engineering sciences in medicine2025

Evaluating the prognostic value of radiomics and clinical features in metastatic prostate cancer using [

Kaylee Molin, Nathaniel Barry, Suki Gill, Ghulam Mubashar Hassan, Roslyn J Francis, Jeremy S L Ong, Martin A Ebert, Jake Kendrick

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Physical and engineering sciences in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Automated lesion tracking and treatment response classification on [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kaylee MolinSchool of Physics, Mathematics and Computing, University of Western Australia, Crawley, WA, Australia. 22734429@student.uwa.edu.au.ORCID http://orcid.org/0009-0006-8445-051X
Nathaniel BarrySchool of Physics, Mathematics and Computing, University of Western Australia, Crawley, WA, Australia.ORCID http://orcid.org/0000-0002-9009-5909
Suki GillDepartment of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.ORCID http://orcid.org/0000-0001-9755-7232
Ghulam Mubashar HassanSchool of Physics, Mathematics and Computing, University of Western Australia, Crawley, WA, Australia.ORCID http://orcid.org/0000-0002-6636-8807
Roslyn J FrancisDepartment of Nuclear Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.ORCID http://orcid.org/0000-0002-6256-1351
Jeremy S L OngDepartment of Nuclear Medicine, Fiona Stanley Hospital, Murdoch, WA, Australia.ORCID http://orcid.org/0000-0001-5101-6107
Martin A EbertSchool of Physics, Mathematics and Computing, University of Western Australia, Crawley, WA, Australia.ORCID http://orcid.org/0000-0002-6875-0719
Jake KendrickSchool of Physics, Mathematics and Computing, University of Western Australia, Crawley, WA, Australia.ORCID http://orcid.org/0000-0001-6524-539X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer is a significant global health issue due to its high incidence and poor outcomes in metastatic disease. This study aims to develop models predicting overall survival for patients with metastatic biochemically recurrent prostate cancer, potentially helping to identify high-risk patients and enabling more tailored treatment options. A multi-centre cohort of 180 such patients underwent [

Indexed as

Edetic AcidOligopeptidesPositron Emission Tomography Computed TomographyProstatic NeoplasmsAgedAged, 80 and overGallium IsotopesGallium RadioisotopesHumansImage Processing, Computer-AssistedKaplan-Meier EstimateMaleMiddle AgedNeoplasm MetastasisPrognosisProportional Hazards ModelsEdetic Acidgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesOligopeptidesPSMA-11Prognostic biomarkersProstate cancerPSMA PETRadiomics

Identifiers

PMID39786674
PMCPMC11996952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.